Skip to main content
SUTRO BIOPHARMA, INC. logo

SUTRO BIOPHARMA, INC. — Investor Relations & Filings

Ticker · STRO ISIN · US8693671021 LEI · 5493005U6P15VD25P851 US Manufacturing
Filings indexed 585 across all filing types
Latest filing 2025-08-07 Regulatory Filings
Country US United States of America
Listing US STRO

About SUTRO BIOPHARMA, INC.

https://www.sutrobio.com/

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of precisely designed cancer therapeutics. The company leverages its proprietary, integrated cell-free protein synthesis platform to create novel antibody-drug conjugates (ADCs). This technology enables the development of next-generation ADCs, including those with single and dual payloads, which are designed to offer improved therapeutic profiles for patients with cancer. Sutro is advancing its own pipeline of clinical-stage product candidates to address areas of significant unmet medical need.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2025-08-07 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-29 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-17 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-06-30 English
8-K
Regulatory Filings
2025-06-25 English
8-K
Regulatory Filings
2025-06-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.